BORONSÄUREDERIVATE

European patent · EP3672977 · In force

Register entry

Publication number
EP3672977
Application number
EP18755481
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 21, 2018
Published
Jul 1, 2020
Granted
Jun 22, 2022
Protection ends at the latest
Aug 20, 2038
Next annual fee due
Aug 31, 2027
IPC classes
C07F 5/02 (2006.01)
A61K 31/69 (2006.01)
A61P 35/00 (2006.01)
Priority
EP 17187636 24.08.2017
PCT application
PCT/EP2018/072485 21.08.2018
PCT publication
WO2019/038250 28.02.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Sep 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.08.2025 → 31.08.2026

    Published in Swissreg on 01.09.2025

  3. Sep 1, 2024

    Next annual fee due on

    Next annual fee due on
    31.08.2024 → 31.08.2025

    Published in Swissreg on 01.09.2024

  4. Sep 1, 2023

    Change

    Published in Swissreg on 01.09.2023

  5. May 3, 2023

    Change

    Published in Swissreg on 03.05.2023

  6. Sep 1, 2022

    Change

    Published in Swissreg on 01.09.2022

  7. Jun 22, 2022

    Granted

    Published in Swissreg on 22.06.2022

Parties

Holder

Merck Patent GmbH

Frankfurter Strasse 250, 64293 Darmstadt, DE

Inventor

KLEIN, Markus

64291 Darmstadt, DE

ESDAR, Christina

64287 Darmstadt, DE

SCHADT, Oliver

63517 Rodenbach, DE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.